Skip to content
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Pulmonology

Why Are Biopsy, PET/CT, and Bronchoscopy Used for RP?

At a Glance

In relapsing polychondritis, no single test is required for everyone. Doctors may use biopsy to support the diagnosis, PET/CT to map hidden inflammation, and dynamic CT, breathing tests, or bronchoscopy to assess airway narrowing or collapse and plan safely around breathing risks.

Being diagnosed with a rare condition like relapsing polychondritis (RP) can be overwhelming, especially when discussing tests to evaluate your airways. The diagnosis of RP is primarily based on your symptoms and clinical exams, but your doctor may order a biopsy, PET/CT scan, or bronchoscopy to confirm inflammation, check for hidden disease, or rule out other conditions [1][2]. While these tests provide valuable information, they are not all required for every patient.

Urgent Safety Warning: Airway involvement in RP can become dangerous quickly. Do not wait for a scheduled test or appointment if you develop sudden or rapidly worsening shortness of breath, new noisy breathing (stridor), an inability to speak in full sentences, blue lips, fainting, or severe chest retractions. Seek emergency medical care immediately.

Biopsy: Examining Tissue Under a Microscope

A biopsy involves numbing the area and removing a small piece of tissue to examine. You may have some pain, a risk of infection, or minor scarring afterward.

What it can show: A biopsy may support an RP diagnosis by showing chondritis (active inflammation of the cartilage) [3]. It is one piece of the puzzle that helps your doctor evaluate for other conditions that can resemble RP, such as granulomatosis with polyangiitis (GPA), IgG4-related disease, sarcoidosis, or lymphoma [4][5].

Limitations and when it may not be necessary: A biopsy is not always needed; many patients are diagnosed based on clinical symptoms alone [1]. Furthermore, a negative biopsy does not mean you do not have RP, as the sample might have missed the inflamed area. If a biopsy is needed, sampling the ear (auricular) cartilage is often preferred because it is much more accessible and safer than the airway, though it still carries a small risk of cosmetic changes [6][7]. Also, a biopsy alone cannot rule out every mimic; for example, VEXAS syndrome (a separate inflammatory condition) requires genetic blood testing [8].

PET/CT Scans: Mapping Metabolic Activity

A PET/CT scan involves an injection of a radioactive sugar (FDG) followed by a scan that highlights areas of high metabolic activity in the body. It does involve radiation exposure and may require you to follow specific diet instructions beforehand.

What it can show: A PET/CT scan is an adjunct test that may identify areas of cartilage inflammation that are not yet causing symptoms, such as in the ribs or airways [2][9]. It can also help locate a lower-risk area to biopsy if one is needed [7].

Limitations and alternatives: High metabolic activity on a PET scan is not specific to RP. Abnormal uptake can be caused by infections, arthritis, tumors, or other forms of vasculitis [10][11]. A negative scan also does not guarantee your airways are free of disease [6].

Non-Invasive Airway Tests: Dynamic CT and PFTs

To check if RP is affecting your breathing, doctors often start with non-invasive tests to map the airway before considering a bronchoscopy [12].

  • Dynamic Chest CT: A CT scan (which involves radiation) taken while you breathe all the way in and out. It can show thickening of the airway walls or areas where the airway collapses during exhalation (tracheobronchomalacia) [12][13].
  • Pulmonary Function Tests (PFTs): Breathing tests that measure airflow and lung volume.

While these tests are excellent complementary tools and are often sufficient for stable patients, they have limitations. PFTs can appear normal in early disease, and neither test allows the doctor to directly inspect the airway lining [14].

Bronchoscopy: Direct Airway Inspection

A bronchoscopy involves mild sedation or anesthesia and passing a flexible camera down the throat to look directly at the vocal cords, trachea, and lower airways.

What it can show: Bronchoscopy directly visualizes inflamed tissue, swelling, and airway narrowing (stenosis) that other tests might miss [15][16]. It is critical if you have concerning symptoms, if imaging is unclear, or if a therapeutic intervention is needed.

Risks and Safety Planning: Bronchoscopy is generally safe, but for RP patients with severe central airway disease or limited respiratory reserve, it carries higher risks. The procedure can cause bronchospasm (sudden airway tightening) or temporary airway collapse [12][17]. Your doctor will evaluate your overall risk using your full lung function assessment, including your oxygenation, flow-volume loops, and forced vital capacity (FVC) [17][18].

If you need a bronchoscopy, it should ideally be performed by an experienced multidisciplinary team, including interventional pulmonologists and anesthesiologists [19]. For highly selected patients with severe disease, the team may prepare specialized contingency plans, such as using positive airway pressure (CPAP) to keep the airway open. In extremely rare, life-threatening situations at specialized centers, they may plan to use ECMO (a machine that temporarily oxygenates the blood) as a rescue measure [20][21][22]. ECMO is a rare contingency, not a routine requirement for every RP bronchoscopy.

Comparing the Tests

Test Main Purpose What it Shows Key Limitations & Risks
Biopsy Evaluate tissue for diagnosis Cartilage inflammation (chondritis) Pain, scarring; negative result doesn’t rule out RP.
PET/CT Map inflammation Clinically silent inflammation Radiation; abnormal results can be from infection or cancer.
Dynamic CT / PFTs Non-invasive airway assessment Airway narrowing and collapse Radiation (CT); may not detect early disease.
Bronchoscopy Direct airway inspection Mucosal inflammation and structure Requires sedation; carries risks for patients with severe airway disease.

Common questions in this guide

Is a biopsy always needed to diagnose relapsing polychondritis?
No. Many people are diagnosed from their symptoms and examination, so a biopsy is not required in every case. When performed, it may show cartilage inflammation and help doctors look for other conditions with similar features; a negative sample does not completely rule out relapsing polychondritis.
What can a PET/CT scan show in relapsing polychondritis?
A PET/CT can highlight areas of increased activity and may reveal cartilage inflammation that is not yet causing symptoms. It can also help identify a safer place for biopsy. Increased uptake is not specific and may also occur with infection, arthritis, tumors, or other vessel inflammation.
Can noninvasive tests check my airways before bronchoscopy?
Often, doctors use a dynamic chest CT and pulmonary function tests first. CT can show airway wall thickening or collapse during exhalation, while breathing tests measure airflow and lung volume. These tests may be enough for stable patients but may miss early disease and cannot show the airway lining directly.
Why would I need a bronchoscopy for relapsing polychondritis?
Bronchoscopy lets the team directly view the vocal cords, windpipe, and lower airways, including inflammation or narrowing that other tests may miss. It may be considered when symptoms are concerning, imaging is unclear, or an airway treatment is needed. Severe airway disease or limited breathing reserve can increase its risk.
How can doctors make bronchoscopy safer in relapsing polychondritis?
Your team reviews your oxygen level, breathing-test results, airflow patterns, and forced vital capacity before the procedure. When risk is higher, bronchoscopy can involve experienced airway and anesthesia specialists with plans for problems such as airway tightening or collapse. Positive airway pressure may be prepared in selected cases, while ECMO is an extremely rare rescue option at specialized centers.
Which breathing symptoms need emergency care while I am waiting for testing?
Seek emergency medical care for sudden or rapidly worsening shortness of breath, new noisy breathing, inability to speak in full sentences, blue lips, fainting, or severe pulling in of the chest when breathing. These symptoms can signal dangerous airway involvement and should not wait for a scheduled test or appointment.

Get notified when new evidence is published on Relapsing polychondritis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (22)
  1. 1

    Relapsing Polychondritis Presenting With Hoarseness and Multisystem Involvement: A Diagnostic and Therapeutic Challenge.

    De Silva S, De Silva M, De Silva PK

    Cureus 2024; (16(11)):e74874 doi:10.7759/cureus.74874.

    PMID: 39741616
  2. 2

    Fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis, assessment of disease activity and therapeutic response in relapsing polychondritis.

    Sharma A, Kumar R, Mb A, et al.

    Rheumatology (Oxford, England) 2020; (59(1)):99-106 doi:10.1093/rheumatology/kez243.

    PMID: 31236569
  3. 3

    Relapsing polychondritis: A clinical update.

    Longo L, Greco A, Rea A, et al.

    Autoimmunity reviews 2016; (15(6)):539-43.

    PMID: 26876384
  4. 4

    Intermittent fever and cough in a 56-year-old patient: Relapsing polychondritis and extranodal NK/T-cell lymphoma.

    Huang Q, Cui D, Chen J, et al.

    Rheumatology and immunology research 2023; (4(1)):40-43 doi:10.2478/rir-2023-0006.

    PMID: 37138649
  5. 5

    Corticosteroid Therapy for a Patient with Relapsing Polychondritis Complicated by IgG4-Related Disease.

    Yamasue M, Nureki S, Matsumoto H, et al.

    The Tohoku journal of experimental medicine 2016; (239(3)):223-30 doi:10.1620/tjem.239.223.

    PMID: 27396510
  6. 6

    Is 18F-FDG PET/CT useful for diagnosing relapsing polychondritis with airway involvement and monitoring response to steroid-based therapy?

    Zeng Y, Li M, Chen S, et al.

    Arthritis research & therapy 2019; (21(1)):282 doi:10.1186/s13075-019-2083-8.

    PMID: 31831053
  7. 7

    FDG-PET/CT and Auricular Cartilage Biopsy Are Useful for Diagnosing with Relapsing Polychondritis in Patients without Auricular Symptoms.

    Okuda S, Hirooka Y, Itami T, et al.

    Life (Basel, Switzerland) 2021; (11(9)) doi:10.3390/life11090956.

    PMID: 34575105
  8. 8

    Defining Clinical Subgroups in Relapsing Polychondritis: A Prospective Observational Cohort Study.

    Ferrada M, Rimland CA, Quinn K, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2020; (72(8)):1396-1402 doi:10.1002/art.41270.

    PMID: 32249511
  9. 9

    The utility of 18F-fluorodeoxyglucose PET/computed tomography in relapsing polychondritis: a systematic review and meta-analysis.

    Malik P, Saraswat D, Aggarwal P, et al.

    Nuclear medicine communications 2026; (47(10)):1117-1125 doi:10.1097/MNM.0000000000002188.

    PMID: 42712171
  10. 10

    Clinical Value of FDG-PET/CT for the Evaluation of Rheumatic Diseases: Rheumatoid Arthritis, Polymyalgia Rheumatica, and Relapsing Polychondritis.

    Kubota K, Yamashita H, Mimori A

    Seminars in nuclear medicine 2017; (47(4)):408-424 doi:10.1053/j.semnuclmed.2017.02.005.

    PMID: 28583280
  11. 11

    Lung Cancer Complicated by Relapsing Polychondritis.

    Arakawa S, Nakao M, Sone K, et al.

    Internal medicine (Tokyo, Japan) 2023; (62(7)):1049-1054 doi:10.2169/internalmedicine.0203-22.

    PMID: 36070940
  12. 12

    Tracheobronchial involvement of relapsing polychondritis.

    de Montmollin N, Dusser D, Lorut C, et al.

    Autoimmunity reviews 2019; (18(9)):102353 doi:10.1016/j.autrev.2019.102353.

    PMID: 31323366
  13. 13

    A Case of Relapsing Polychondritis With Severe Obstructive Ventilatory Defect Caused by a Single Flare-Up.

    Nakagawa R, Kishimoto A, Namiki T, et al.

    Respirology case reports 2025; (13(11)):e70415 doi:10.1002/rcr2.70415.

    PMID: 41262648
  14. 14

    Relapsing polychondritis: tracheobronchial involvement and differential diagnoses.

    Grandière L, Vicaire H, Pop G, et al.

    Journal of thoracic disease 2025; (17(1)):461-475 doi:10.21037/jtd-24-1603.

    PMID: 39975747
  15. 15

    Pre-treatment bronchoscopic evaluation in a case of relapsing polychondrits.

    Kumagai K, Tsuruoka H, Morikawa K, et al.

    BMC pulmonary medicine 2023; (23(1)):108 doi:10.1186/s12890-023-02400-z.

    PMID: 37013530
  16. 16

    Unveiling the clinical and proteomic spectrum of relapsing polychondritis with respiratory involvement.

    Fang X, Liao X, Gao W, et al.

    Frontiers in immunology 2026; (17()):1866652 doi:10.3389/fimmu.2026.1866652.

    PMID: 42597969
  17. 17

    Risk factors associated with severe adverse events in patients with relapsing polychondritis undergoing flexible bronchoscopy.

    Wang ST, Wang J, Gao X, et al.

    Orphanet journal of rare diseases 2024; (19(1)):54 doi:10.1186/s13023-024-03061-9.

    PMID: 38336719
  18. 18

    Relapsing Polychondritis With Severe Airway Involvement Mimicking Refractory Asthma: A Diagnostic Challenge.

    Beladev S, Dubey M, Patel S

    Cureus 2026; (18(9)):e116342 doi:10.7759/cureus.116342.

    PMID: 42891473
  19. 19

    Tracheobronchomalacia and Excessive Dynamic Airway Collapse: Medical and Surgical Treatment.

    Kheir F, Majid A

    Seminars in respiratory and critical care medicine 2018; (39(6)):667-673 doi:10.1055/s-0038-1676571.

    PMID: 30641584
  20. 20

    Bronchoscopy-Guided Intervention Therapy With Extracorporeal Membrane Oxygenation Support for Relapsing Polychondritis With Severe Tracheobronchomalacia: A Case Report and Literature Review.

    Zhou P, Fu B, Zhang C, et al.

    Frontiers in medicine 2021; (8()):695505 doi:10.3389/fmed.2021.695505.

    PMID: 34888317
  21. 21

    Relapsing polychondritis with catastrophic tracheal injury: extracorporeal membrane oxygenation and silicone Y-stenting for salvage therapy.

    Kuo IC, Chou PL, Cheng YT, et al.

    Journal of cardiothoracic surgery 2025; (20(1)):384 doi:10.1186/s13019-025-03627-z.

    PMID: 41126302
  22. 22

    Respiratory subtype of relapsing polychondritis frequently presents as difficult asthma: a descriptive study of respiratory involvement in relapsing polychondritis with 13 patients from a single UK centre.

    Dubey S, Gelder C, Pink G, et al.

    ERJ open research 2021; (7(1)) doi:10.1183/23120541.00170-2020.

    PMID: 33614776

This page explains why diagnostic tests may be used in relapsing polychondritis for informational purposes only and does not constitute medical advice. Your treating team should decide which tests are appropriate and how to manage your individual airway risk.